Trump drug price plan could nix investment, warns Roche / Photo: SEBASTIEN BOZON - AFP
-
Trump takes centre stage as 2026 World Cup draw takes place
-
Trump all smiles as he wins FIFA's new peace prize
-
US panel votes to end recommending all newborns receive hepatitis B vaccine
-
Title favourite Norris reflects on 'positive' Abu Dhabi practice
-
Stocks consolidate as US inflation worries undermine Fed rate hopes
-
Volcanic eruptions may have brought Black Death to Europe
-
Arsenal the ultimate test for in-form Villa, says Emery
-
Emotions high, hope alive after Nigerian school abduction
-
Another original Hermes Birkin bag sells for $2.86 mn
-
11 million flock to Notre-Dame in year since rising from devastating fire
-
Gymnast Nemour lifts lid on 'humiliation, tears' on way to Olympic gold
-
Lebanon president says country does not want war with Israel
-
France takes anti-drone measures after flight over nuclear sub base
-
Signing up to DR Congo peace is one thing, delivery another
-
'Amazing' figurines find in Egyptian tomb solves mystery
-
Palestinians say Israeli army killed man in occupied West Bank
-
McLaren will make 'practical' call on team orders in Abu Dhabi, says boss Brown
-
Stocks rise as investors look to more Fed rate cuts
-
Norris completes Abu Dhabi practice 'double top' to boost title bid
-
Chiba leads Liu at skating's Grand Prix Final
-
Meta partners with news outlets to expand AI content
-
Mainoo 'being ruined' at Man Utd: Scholes
-
Guardiola says broadcasters owe him wine after nine-goal thriller
-
Netflix to buy Warner Bros. Discovery in deal of the decade
-
French stars Moefana and Atonio return for Champions Cup
-
Penguins queue in Paris zoo for their bird flu jabs
-
Netflix to buy Warner Bros. Discovery for nearly $83 billion
-
Sri Lanka issues fresh landslide warnings as toll nears 500
-
Root says England still 'well and truly' in second Ashes Test
-
Chelsea's Maresca says rotation unavoidable
-
Italian president urges Olympic truce at Milan-Cortina torch ceremony
-
Norris edges Verstappen in opening practice for season-ending Abu Dhabi GP
-
Australia race clear of England to seize control of second Ashes Test
-
Stocks, dollar rise before key US inflation data
-
Trump strategy shifts from global role and vows 'resistance' in Europe
-
Turkey orders arrest of 29 footballers in betting scandal
-
EU hits X with 120-mn-euro fine, risking Trump ire
-
Arsenal's Merino has earned striking role: Arteta
-
Putin offers India 'uninterrupted' oil in summit talks with Modi
-
New Trump strategy vows shift from global role to regional
-
World Athletics ditches long jump take-off zone reform
-
French town offers 1,000-euro birth bonuses to save local clinic
-
After wins abroad, Syria leader must gain trust at home
-
Slot spots 'positive' signs at struggling Liverpool
-
Eyes of football world on 2026 World Cup draw with Trump centre stage
-
South Africa rugby coach Erasmus extends contract until 2031
-
Ex-Manchester Utd star Lingard announces South Korea exit
-
Australia edge ominously within 106 runs of England in second Ashes Test
-
Markets rise ahead of US data, expected Fed rate cut
-
McIlroy survives as Min Woo Lee surges into Australian Open hunt
NYSE - LSE
| RBGPF | 0% | 78.35 | $ | |
| CMSC | -0.34% | 23.4 | $ | |
| RIO | -0.5% | 73.365 | $ | |
| AZN | 0.23% | 90.24 | $ | |
| SCS | -0.5% | 16.149 | $ | |
| BCC | -1.5% | 73.16 | $ | |
| GSK | -0.75% | 48.21 | $ | |
| BP | -2.69% | 36.255 | $ | |
| BTI | -1.49% | 57.19 | $ | |
| NGG | -0.57% | 75.48 | $ | |
| RELX | -0.32% | 40.41 | $ | |
| CMSD | -0.32% | 23.245 | $ | |
| BCE | 1.04% | 23.465 | $ | |
| JRI | 0.22% | 13.78 | $ | |
| RYCEF | -0.96% | 14.51 | $ | |
| VOD | -1.14% | 12.49 | $ |
Trump drug price plan could nix investment, warns Roche
President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in the United States, it said Wednesday.
Trump signed an executive order Monday aimed at bringing down the notoriously high prescription drug prices paid by US consumers, news that rattled pharmaceutical companies.
Swiss newspaper NZZ reported Trump's move could lead Roche to reassess plans it announced just last month to invest $50 billion in the United States over five years.
Roche, the world leader in cancer treatments, said in a statement it did not expect Trump's new drugs policy to hurt its business in 2025.
"However, should the proposed EO (executive order) go into effect, Roche's ability to fund the significant investments previously announced in the US will be in question," it said.
Trump has been pushing foreign firms to invest more in the United States, saying the way to avoid his tariff assault on foreign-made goods is to produce them on US soil instead.
Prescription drugs were not targeted in Trump's "Liberation Day" tariff announcements.
Still, Roche appeared to take heed with its April investment announcement, which came just after fellow Swiss rival Novartis said it would increase investment in the United States by $23 billion over five years.
The United States is a key market for Roche, accounting for more than half its pharmaceutical division's revenues.
Roche's US subsidiary Genentech announced a $700-million project Monday to build a new plant in North Carolina, which it says would employ 400 people.
E.Hall--AT
